What is the recommended dosage and administration guidelines for Versed (midazolam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midazolam (Versed) Dosage and Administration Guidelines

For adult patients requiring sedation, the recommended initial dose of midazolam is 1-2 mg IV administered over 2 minutes, with titration in small increments to the desired effect, not exceeding 5 mg total dose in healthy adults under 60 years. 1

Adult Dosing Guidelines

Intravenous Administration

  • Initial dose for healthy adults under 60 years: 1-2 mg (0.03 mg/kg) IV administered over 2 minutes 1
  • Wait 2 or more minutes to evaluate sedative effect before administering additional doses 1
  • Titrate in small increments (1 mg) until desired effect (e.g., slurred speech) 1
  • Total dose rarely exceeds 5 mg in healthy adults 1
  • For patients receiving opioids or other CNS depressants, reduce midazolam dose by approximately 30% 1

Special Populations

  • Adults 60 years or older: Initial dose 1-1.5 mg IV over 2 minutes; total dose rarely exceeds 3.5 mg 1
  • Debilitated or chronically ill patients: Reduce dose by 50% compared to healthy adults 1
  • Patients with hepatic or renal impairment: Reduce dose due to decreased clearance 2

Intramuscular Administration

  • Preoperative sedation: 0.07-0.08 mg/kg IM (approximately 5 mg) administered up to 1 hour before procedure 1
  • Inject deep into large muscle mass 1
  • Onset within 15 minutes, peak effect at 30-60 minutes 1

Continuous Infusion

  • For critical care sedation: Initial IV loading dose of 0.05-0.2 mg/kg administered over 2-3 minutes 1
  • Maintenance infusion: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 1
  • Adjust rate by 25% of initial rate as needed based on clinical response 1

Pediatric Dosing

  • 6 months to 5 years: Initial dose 0.05-0.1 mg/kg IV; total dose up to 0.6 mg/kg (not exceeding 6 mg) 1, 3
  • 6-12 years: Initial dose 0.025-0.05 mg/kg IV; total dose up to 0.4 mg/kg (not exceeding 10 mg) 1, 3
  • 12-16 years: Dose as adults 1
  • For seizures: 0.05-0.1 mg/kg IV/IM (maximum 4 mg per dose), may repeat every 10-15 minutes if needed 2

Administration Precautions

  • Always titrate slowly, administering over at least 2 minutes 1
  • Allow 2 or more minutes between doses to fully evaluate sedative effect 1
  • Ensure immediate availability of resuscitative equipment and personnel trained in airway management 1
  • Monitor oxygen saturation continuously during administration 2
  • Reduce dose when used with other CNS depressants, especially opioids 1

Potential Adverse Effects

  • Respiratory depression and apnea, especially when combined with opioids 4, 5
  • Hypotension, particularly in elderly, critically ill patients, or with rapid administration 1
  • Paradoxical reactions including agitation, anxiety, and insomnia 6
  • Hiccups, cough, nausea, and vomiting 4

Reversal Agent

  • Flumazenil can reverse midazolam-induced sedation in emergency situations 7
  • Typical flumazenil dose: 0.2-0.4 mg IV every 2-3 minutes until desired response 6

Clinical Pearls

  • Midazolam is approximately 2-4 times more potent than diazepam 4, 8
  • Half-life is approximately 1 hour in healthy adults but may be prolonged in renal or hepatic dysfunction 4
  • Water-soluble in commercial formulation but becomes lipid-soluble at physiological pH, allowing rapid CNS penetration 3
  • Metabolized by cytochrome P450 enzyme system; drug interactions possible with inhibitors like cimetidine 4

Remember that careful titration to clinical effect and close monitoring are essential for safe administration of midazolam in all patient populations.

References

Guideline

Midazolam Dosing for Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Midazolam: a review of therapeutic uses and toxicity.

The Journal of emergency medicine, 1997

Research

Midazolam use in the emergency department.

The American journal of emergency medicine, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reversal of midazolam sedation with flumazenil.

Critical care medicine, 1992

Research

Use of midazolam hydrochloride in anesthesia.

Clinical pharmacy, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.